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ABSTRACT 
Recently, the biosafety and potential influences of nanoparticles on central nervous system have received more 
attention. In the present study, we assessed the effect of aluminium oxide nanoparticles (Al2O3-NPs) on spatial 
cognition. Male Wistar rats were intravenously administered Al2O3-NP suspension (20 mg/kg body weight/day) 
for four consecutive days, after which they were assessed. The results indicated that Al2O3-NPs impaired spatial 
learning and memory ability. An increment in malondialdehyde levels with a concomitant decrease in superoxide 
dismutase activity confirmed the induction of oxidative stress in the hippocampus. Additionally, our findings 
showed that exposure to Al2O3-NPs resulted in decreased acetylcholinesterase activity in the hippocampus. Fur-
thermore, Al2O3-NPs enhanced aluminium (Al) accumulation and disrupted mineral element homoeostasis in the 
hippocampus. However, they did not change the morphology of the hippocampus. Our results show a connection 
among oxidative stress, disruption of mineral element homoeostasis, and Al accumulation in the hippocampus, 
which leads to spatial memory deficit in rats treated with Al2O3-NPs. 
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INTRODUCTION 
Nanoparticles (NPs) have several indus-
trial, military, and medical applications, 
among other uses. In nanotechnology, the de-
vices or engineered materials used have sizes 
ranging from 1 to 100 nm (Borm et al., 2006; 
Oberdörster et al., 2005; Sajid et al., 2015). 
NPs can have negative impacts on the envi-
ronment and cause many diseases because of 
their specific properties, which include high 
surface reactivity, shape, and special structure 
(Amara et al., 2014; Chen et al., 2008; Ober-
dörster et al., 2005; Sajid et al., 2015). Cellu-
lar uptake and penetration of NPs into the 
blood and lymph are easy because of the small 
size of such particles (Chen et al., 2008; 
Oberdörster et al., 2005). NPs may be depos-
ited in different body organs and tissues; how-
ever, their accumulation at body sites can lead 
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to toxicity (Åkerman et al., 2002; Ballou et 
al., 2004; Borm et al., 2006; De Jong et al., 
2008). Furthermore, some studies have shown 
that NPs can cross the blood brain barrier 
(BBB) (Chen et al., 2008; Cupaioli et al., 
2014). It has been found that NPs can provoke 
neurotoxicity and alter cognitive functions in 
mice and rats. In addition, the aforementioned 
effects were found to be a function of NP 
type, duration of treatment, and administered 
dose (Lockman et al., 2004; Sharma and 
Sharma, 2007; Sharma et al., 2012). 
Aluminium oxide nanoparticles (Al2O3-
NPs) are abundantly produced and used in 
various consumer, medical, domestic, and in-
dustrial products (Balasubramanyam et al., 
2009; Monterio-Riviere et al., 2010). They 
also have various military applications 
(Miziolek, 2002). Aluminium nanoparticles 
(Al-NPs) are used as fuel in propellants, as 
they have a high enthalpy of combustion and 
a pyrotechnic characteristic (Ghanta and 
Muralidharan, 2013; Miziolek, 2002; Wagner 
et al., 2007). They are also used to manufac-
ture electrical components and batteries 
(Piercey and Klapoetke, 2010). It has been 
proposed that Al-NPs can be used as a carrier 
system to increase drug solubility (Tyner et 
al., 2004) . 
Previous studies have shown that Al im-
pairs the cholinergic system and causes learn-
ing deficits (Abdel-Aal et al., 2011; Kumar et 
al., 2009). Al can also provoke cell depletion 
in the cortex and hippocampus (Kumar et al., 
2011; Wang et al., 2014). Consequently, it 
can affect learning and memory ability. How-
ever, the mechanism by which Al induces a 
negative effect on memory is not clearly un-
derstood yet.  
Some studies on the toxicity of Al2O3-NPs 
have indicated that the particles change spa-
tial cognition capability. In addition, a study 
conducted on experimental animal brains 
showed that Al2O3-NPs may cause oxidative 
stress by damaging membrane lipids and dis-
turbing the antioxidative enzyme defence sys-
tem (Karmakar et al., 2014; Prabhakar et al., 
2012; Shah et al., 2015). Furthermore, it has 
been demonstrated in different rodents that 
Al2O3-NPs can cause neurotoxicity by induc-
ing cytotoxic effects, genotoxic effects, and 
inflammatory events in the brain (Chen et al., 
2008; Li et al., 2009; Prabhakar et al., 2012; 
Shrivastava et al., 2014). 
There is limited information on the tox-
icity of Al-NPs to the brain. Therefore, in the 
present study, we assessed the effect of 
Al2O3-NPs on spatial memory. Additionally, 
we investigated the response profiles of oxi-
dative stress and acetylcholinesterase (AChE) 
activity in the hippocampus. Furthermore, Al 
accumulation, mineral element homoeostasis, 
and the morphology of the hippocampus were 
also analysed. 
 
MATERIALS AND METHODS 
Animals 
Twenty-four male Wistar rats (180–
220 g), 2-3 months old, were obtained from 
SIPHAT (Ben Arous, Tunisia) for the study. 
The animals were acclimatised to the study 
environment for at least one week before ex-
periments were conducted. The rats were 
housed in groups (n = 6 per group) in poly-
propylene cages under standard conditions. 
The room was well ventilated and maintained 
at a temperature of 22 ± 4 °C. Additionally, 
the animals were kept under a 12/12 h 
light/dark cycle (light on at 09:00 AM and 
light off at 09:00 PM) and allowed free access 
to water and food. The protocols used in this 
work were approved by the Medical Ethical 
Committee for the Care and Use of Labora-
tory Animals of Pasteur Institute of Tunis (ap-
proval number: LNFP/Pro 152012). 
 
Drugs 
Al2O3-NPs (Cat No. 544833; Sigma-Al-
drich, St. Louis, MO, USA) were used in this 
study as a dry powder. The product specifica-
tions are as follows: gamma phase alumina 
NPs; particle size, ˂ 50 nm (transmission 
electron microscopy, TEM); and surface area, 
40 m2/g (Brunauer-Emmett-Teller).  
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Characterisation of Al2O3-NPs 
TEM analysis  
The particle size and shape of the Al2O3-
NPs were determined using a Tecnai G2-
200KV system (FEI Company, Hillsboro, 
OR, USA). Sample preparation for observa-
tion by TEM was done as follows. First, the 
powder was mixed with EtOH, after which ul-
trasonic dispersed particles were deposited 
onto a lacey-carbon-coated copper grid.  
Powder X-ray diffraction (XRD) analysis 
The crystal structure of the NPs was as-
sessed by powder XRD using an advanced X-
ray diffractometer (D8 Advance; Bruker Cor-
poration, Billerica, MA, USA) at 40 kV and 
30 mA. Scanning was performed with 2.2 kW 
Cu anode radiation at a wavelength of 
1.54 A˚. About 250 mg of Al2O3 was depos-
ited on the sample holder for scanning over a 
range of 10–100 °C.  
 
Treatment  
Al2O3-NPs were suspended in fresh steri-
lised physiological saline solution (9 ‰ so-
dium chloride) at a concentration of 20 mg/ 
ml. The suspension was sonicated (Vibra-Cell 
model CV 18; Sonics, Newtown, CT, USA) 
for 30 min before it was administered (Amara 
et al., 2014). In order to prevent Al2O3-NP ag-
glomeration, the temperature of the sonicator 
was kept below 30 °C. The animals were di-
vided into control (n = 12, saline injection) 
and Al2O3-NP (n = 12, Al2O3-NP injection at 
20 mg/kg body weight) groups. Each treat-
ment was administered daily via the tail vein 
for four consecutive days.  
 
Spatial navigation task  
Twenty-four hours after the last Al2O3-NP 
injection was administered, the rats were sub-
jected to spatial reference memory tests for 
five consecutive days. 
The Morris water maze test was per-
formed to assess spatial memory and learning 
ability. The test was performed following the 
method described by Morris (1984) with mi-
nor modifications (Deguil et al., 2010) . The 
water maze consisted of a circular water pool 
(100 cm, diameter; 60 cm, height) that was 
virtually divided into four equal quadrants. 
The pool was placed in a room that was dec-
orated with many cues and filled with water 
(22 ± 2 °C) to a height of 30 cm. The test was 
conducted in two sessions: the hidden plat-
form test (acquisition session), during which 
we evaluated the latency to reach a platform 
placed at the north-eastern side of the device; 
and the probe test (without platform). The test 
was initiated by placing a rat in the pool fac-
ing the pool wall and allowing the animal to 
swim freely during the first trial to the visible 
platform. The animal was then allowed to 
swim to the submerged platform, which was 
placed 1 cm under the water surface, in three 
other trials. For each trial, the rats were ex-
pected to find the platform for within a maxi-
mum of 60 s. If an animal failed to find the 
platform after 60 s, it was guided to it by the 
researcher. It was then allowed to stay on the 
platform for 10 s, after which it was removed 
from the pool before the next trial was started. 
Each rat was subjected to four trials per day 
for four consecutive days. The test was started 
at 09:00 AM each day. There was 10-min in-
ter-trial interval between two consecutive tri-
als. Daily escape latency for each rat was cal-
culated as the average of the results from the 
four trials. Probe trial was performed on the 
fifth day. In this test, the platform was re-
moved from the pool and the animals were al-
lowed 60 s to swim freely. The swimming 
time in the quadrant where the platform was 
placed during the first four days (North-East) 
was recorded. 
 
Biochemical analyses 
Tissue preparation  
After the last trial, the animals were sacri-
ficed by decapitation. The brains were care-
fully excised on ice-cooled glass plates, im-
mediately rinsed with physiological solution, 
dried with filter paper, and weighed. Hippo-
campi were immediately isolated, set in liquid 
nitrogen, and then stored at -80 °C until anal-
ysis. Each sample was homogenised in phos-
phate-buffered saline (pH 7.4). The homoge-
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nates were centrifuged at 600 g and then re-
centrifuged at 13 000 g for 20 min at 4 °C. 
The protein, malondialdehyde (MDA), and 
thiol group levels in the supernatants were as-
sessed. In addition, the activities of catalase 
(CAT), superoxide dismutase (SOD), gluta-
thione peroxidase (GPx), and acetylcholines-
terase (AChE) were evaluated.  
Antioxidant enzyme assays 
Total protein level in the hippocampus 
was determined as previously described 
(Hartree, 1972) using bovine serum albumin 
as the standard. Lipoperoxidation was esti-
mated spectrophotometrically at 532 nm by 
measuring brain MDA level (Ohkawa et al. 
1979). The results were expressed in nmoles 
of MDA/mg of protein. CAT activity was as-
sayed by ultraviolet spectrophotometry at 240 
nm (Aebi, 1984), after which the results were 
expressed in µmoles H2O2/min/mg of protein. 
SOD activity was determined as previously 
described (Misra and Fridovic, 1972) by spec-
trophotometry at 420 nm. The results of the 
analysis were expressed in U/min/mg of pro-
tein. GPx activity was measured by the 
method described by Flohé and Günzler 
(1984), and expressed in U/mg/min. Tissue 
levels of sulfhydryl groups (expressed in Mm) 
were determined as described by Ellman 
(Ellman, 1959). 
AChE activity 
AChE activity was assessed by the Ellman 
method (Ellman et al., 1961). Changes in ab-
sorbance were measured for 15 min at 30-s in-
tervals at 412 nm using a microplate reader. 
Results were expressed in µmoles of 
acetylthiocholine iodide hydrolysed/min/mg 
of protein (U AChE). 
 
Estimation of Al concentration  
Al concentration in the hippocampus was 
determined as follows. First, each sample was 
incinerated at 550 °C for 48 h in an oven muf-
fle (Stuart, Staffordshire, UK) to obtain a 
white residue, which was then cooled to room 
temperature. Next, 1.25 ml of concentrated 
nitric acid was added to each residue for sam-
ple recovery. The volume of each mixture was 
then increased to 12.5 ml with ultra-pure wa-
ter. Al concentration was measured by induc-
tively coupled plasma-atomic emission spec-
troscopy. 
 
Fe, Ca, and Mg levels 
Ionisable Ca and Mg levels were quanti-
fied using commercial kits (Biomaghreb, Ar-
iana, Tunisia). The level of free Fe was deter-
mined by the ferrozine method (Leardi et al., 
1998) using a commercial kit (Biomaghreb). 
The ferrozine method is based on the follow-
ing. At a pH of 4.8, Fe3+ is liberated from 
transferrin and reduced to Fe2+ by ascorbic 
acid. A colourful complex that is spectropho-
tometrically measurable at 560 nm is formed 
from the reaction between ferrozine and the 
reduced Fe2+ ion.  
 
Histological study 
Immediately after decapitation, brains 
samples from each animal were fixed in 10 % 
formalin for 10 days. The fixed tissues were 
dehydrated in a graded series of ethanol and 
xylene solutions, and then embedded in par-
affin. The brain samples were cut into 5-μm-
thick sections using a microtome, deparaffin-
ised, and rehydrated. Next, the sections were 
stained with haematoxylin and eosin (H&E), 
washed, and dried. Slides of the samples were 
prepared and viewed under a light micro-
scope. Photomicrographs were taken for anal-
ysis. 
 
Statistical analysis 
Results have been presented as mean ± 
standard error of the mean. Behavioural data 
were analysed using two-way analysis of var-
iance, with Al2O3-NP treatment and repeated 
measures as principal factors. In the case of 
significant interaction (p ≤ 0.05), post hoc 
Fisher’s least significant difference analysis 
was used to compare the control and treated 
groups. Oxidative stress data were analysed 
using t-test. 
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RESULTS 
Characterization of aluminum oxide nano-
particles 
TEM analysis 
The TEM measurements (Figure 1A) 
have shown very thin Al2O3 particles (na-
nopowder, < 50 nm).  
Powdered X-ray diffraction (XRD) analysis 
The XRD results (Figure 1B) showed five 
dominant peaks [36.53 u, 37.72 u, 39.46 u, 
47.80 u and 67.01 u], which confirm the crys-
talline nature of the Al2O3-NPs. The same 
peaks were obtained by Pakrashi et al. (2013). 
 
Spatial memory 
The results obtained from the Morris wa-
ter maze test are presented in Figure 2A. A 
significant decrease in the latency to find the 
platform (F(3,30) = 15.17, p ≤ 0.00001) was 
observed throughout the four days in each 
group. Additionally, the time required to get 
to the platform was influenced by treatment 
on the third and fourth days (F(1,10) = 5.30 (p 
≤ 0.05) and F(1,10) = 6.66 (p ≤ 0.05), respec-
tively). The latency to find the platform de-
creased over the course of acquisition training 
(interaction treatment X repeated measure 
F(3,30) = 0.139, p ≥ 0.05). During the probe 
test (Figure 2B), NP-treated animals spent 
significantly less time (28.72 %) in the target 
quadrant (north-eastern side) than the control 
animals did (42.61 %) (F(1,10) = 8.54, p ≤ 
0.05). 
 
Oxidative stress 
Our findings revealed that MDA levels 
significantly increased in the hippocampal tis-
sues of the treated rats (Figure 3). In addition, 
the Al2O3-NP formulation significantly inhib-
ited SOD activity (p ≤ 0.05); however, it did 
not change thiol group levels or the activities 
of CAT and GPx (Table 1). 
 
Figure 1: (A) Transmission electron microscopy (TEM) image of aluminium oxide nanoparticles. 
(B) Characterisation of aluminium oxide nanoparticles (Al2O3-NPs) by X-ray diffraction analysis 
(patterns for the crystal quality of Al2O3-NPs). 
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Figure 2: (A) Latency to find platform in the Morris water maze test (n = 6). Data are averaged by 
day and are presented as mean ± standard error of the mean. (a) Significant diminution in the latency 
to find the platform between days 1 and 3. (b) Significant training effect (p ≤ 0.00001). * indicates signif-
icant difference in the effect of the aluminium oxide nanoparticles (p ≤ 0.05) on the same day of training. 
(B) Time spent in the target quadrant in the Morris water maze test (Probe test). Data are presented 
as mean ± standard error of the mean. * indicates significant difference in the effect of the aluminium 
oxide nanoparticles (p ≤ 0.05). 
 
 
Figure 3: Effect of aluminium oxide nanoparti-
cles (Al2O3-NPs) on malondialdehyde level in 
the hippocampus (n = 6). Data are presented as 
mean ± standard error of the mean. * indicates 
significant difference in the effect of the Al2O3-NPs 
(p ≤ 0.05). 
 
AChE activity 
Our findings showed that the Al2O3-NPs 
significantly inhibited AChE activity in the 
hippocampus (Figure 4). 
 
 
Figure 4: Effect of aluminium oxide nanoparti-
cles (Al2O3-NPs) on acetylcholinesterase ac-
tivity in the hippocampus (n = 6). Data are pre-
sented as mean ± standard error of the mean.  
* indicates significant difference in the effect of the 
Al2O3-NPs (p ≤ 0.05). 
 
 
Al level and mineral content 
Al levels in the control and Al2O3-NP-
treated groups are shown in Table 2. Sub-
acute Al2O3-NP treatment caused a signifi-
cant increase in Al concentration in the hip-
pocampus (p ≤ 0.05), which disturbed mineral 
balance in the hippocampus. Our data showed 
that Mg levels (p ≤ 0.05) were higher in the 
Al2O3-NP-treated group than they were in the 
control group. However, Ca and Fe levels sig-
nificantly deceased in the hippocampi of 
Al2O3-NP-treated rats. 
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Table 1: Effect of four Al2O3-NP injections on CAT, SOD and GPx activities in hippocampus (n = 6) 
 Control group                              Al2O3-NPs group 
SOD (U/mg of protein) 1.19 ± 0.14 0.71 ± 0.07* 
CAT (U/mg of protein) 18.09 ± 3.37 18.28 ±1.85 
GPx (U/mg of protein/min) 0.22 ± 0.02 0.18 ± 0.01 
Thiol groups (Mm) 0.05 ± 0.009 0.04 ± 0.01 
Values are given as mean ± SEM. (*) significant mean Al2O3-NPs treatment effect (p ≤ 0.05) 
 
 
 
Table 2: Al (n = 3) and mineral content (n = 5) in 
hippocampus of rats after four Al2O3-NP injections 
compared to control. Values are expressed in 
µg/g fresh weight. 
 
 Control group        Al2O3-NP group 
Al 0.54 ± 0.054 0.89 ± 0.142* 
Fe 2.93 ± 0.0007 0.43 ± 0.00009* 
Ca 32.69 ± 0.003 25.09 ± 0.001* 
Mg 81.03 ± 0.004 100.95 ± 0.007* 
Values are given as mean ± SEM. (*) significant 
mean Al2O3-NPs treatment effect (p ≤ 0.05) 
 
 
Histological study 
No morphological change was observed 
in the hippocampus of any rat in either group 
(Figure 5). 
 
DISCUSSION 
The purpose of this study was to examine 
the effects of Al2O3-NPs on spatial learning, 
memory, oxidative response, and bio-distri-
bution of Al and other minerals in the rat hip-
pocampus. The spatial learning capacities of 
rats were evaluated in the Morris water maze 
test. Our findings indicated that sub-acute 
Al2O3-NP treatment (20 mg/kg body weight) 
decreased the time needed to reach the plat-
form with training in both groups, suggesting 
that rats in both groups learned to find the 
platform. Nevertheless, the Al2O3-NP-treated 
rats had a lower spatial performance than the 
control rats did, which was revealed by the 
probe test results. Additionally, the rats did 
not learn to accurately locate the escape point 
in the maze. Our findings are consistent with 
those reported by Kumar et al. (2011) and 
Wang et al. (2014), who administered oral (6-
week treatment) and intraperitoneal injections 
(2-month treatment) of Al, respectively, to 
rats in their studies. Similar results were also 
obtained after intracerebral administration of 
Al to rabbits (Rabe et al., 1982). The afore-
mentioned effect of Al in the various labora-
tory animals could be attributed to interfer-
ence with the activities of molecules that are 
implicated in long-term potentiation (Canales 
et al., 2001), which results in learning deficits.  
The hippocampus is the site in the brain 
responsible for memory and learning. Partic-
ularly, the CA1 and CA3 areas are reported to 
be associated with long-term and short-term 
memory consolidation.  
In the present study, Al-NPs were injected 
into systemic pathways. Our findings showed 
an increased Al concentration in the hippo-
campi of the rats. Some authors have indi-
cated that Al2O3-NPs can cross the BBB re-
gardless of the route of administration (Shah 
et al., 2015); however, there is insufficient ev-
idence to confirm that. We believe that NPs 
are absorbed in the brain in their ionic form. 
Al is a neurotoxin that is implicated in some 
neurodegenerative diseases such as Alz-
heimer’s disease (Abdel-Aal et al., 2011; 
Gauthier et al., 2000), in which patients suffer 
deterioration of some abilities such as attent-
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Figure 5: Photomicrographs of the rat hippocampus (H&E staining). No differences were observed 
when the hippocampi of the control (A) and treated rats (B) were compared (magnification=100X).  
 
 
ion, concentration, visual memory, vocabu-
lary scores, and frontal lobe function (Kumar 
et al., 2011). 
Accumulation of Al in the hippocampus 
can partially contribute to the toxicity of 
Al2O3-NPs. This was confirmed in the present 
study by the disruption of spatial learning per-
formance in the Al2O3-NP-treated rats. Many 
neurotransmitters such as acetylcholine 
(ACh) are involved in learning and memory 
processes. AChE activity is a good indicator 
of cholinergic system function (Zatta et al., 
2002). In the present study, significant inhibi-
tion of AChE activity was observed in the hip-
pocampal homogenates of Al-NP-treated rats. 
The same results were reported by Kaizer et 
al. (2008) The authors indicated that, after 
long-term oral administration of Al2Cl3 to 
mice, AChE activity decreased in homoge-
nates of the cerebellum, hippocampus, and 
cerebral cortex of the animals. Furthermore, 
Kumar et al. (2009) reported that Al can dam-
age neurons and lead to depletion in AChE 
level. Moreover, Al alters the BBB and pro-
duces changes in noradrenergic and choliner-
gic neurotransmissions (Yokel, 2000). Al and 
Al2O3-NPs can alter ion homoeostasis, in-
cluding Ca2+ homoeostasis, and decrease the 
release of ACh, which results in decreased 
AChE levels. This was confirmed in the pre-
sent study by the significant decrease in Ca2+ 
levels in the hippocampi of rats treated with 
Al2O3-NPs. It has been suggested that Al in-
terferes with the neurotransmission of gluta-
mate and impairs hippocampal long-term po-
tentiation.  
Oxidative stress is the most common 
mechanism through which toxicity occurs fol-
lowing exposure to NPs (Yang et al., 2009). 
Our results showed that, MDA levels in-
creased significantly while SOD activity de-
creased in the hippocampi of the Al2O3-NP-
treated rats. Sethi et al. (2008) reported simi-
lar findings after administering oral Al to rats. 
Inhibition of SOD activity leads in part to in-
crease in lipid peroxidation (Kumar et al., 
2009). Furthermore, it disturbs Fe homoeosta-
sis, which results in excessive levels of free 
Fe ions, which causes oxidative damage by 
the Fenton reaction and further leads to neu-
rodegeneration. No differences were ob-
served between the two groups with regards 
to thiol group levels and the activities of CAT 
and GPx.  
In addition, our results showed that 
Al2O3-NPs can disrupt the metabolism of 
mineral elements that are necessary for anti-
oxidant enzyme synthesis in the rat brain. 
Flora et al. (2008) reported that the production 
of reactive oxygen species is related to de-
crease in the levels of some antioxidant en-
zyme cofactors such as Fe, Zn, Mg, and Cu. 
In the present work, the most pronounced ox-
idative damage was observed as a result of an 
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excessive MDA level in the hippocampus. 
Moreover, the Al2O3-NPs might have induced 
free radical generation that further initiated li-
pid peroxidation and damaged cellular com-
ponents. Previous studies have shown that Al 
can induce lipid peroxidation in the brain and 
cause neurodegeneration (Kumar et al., 2009; 
Tripathi et al., 2009), which can be confirmed 
by increased MDA levels and inhibition of 
SOD activity in the brain (Morsy et al., 2013). 
Furthermore, Al can cause neuronal inflam-
mation, which leads to a decline in visoper-
ception and attention, and impairment in 
working and semantic memories (Platt et al., 
2001). Our data revealed no difference in hip-
pocampus structure between the control and 
treated groups. 
Al-NPs can alter the neural membrane by 
reducing its lipoprotein integrity (Banks et al., 
2006). This induces partial damage to the 
BBB, which leads to Al accumulation in the 
brain. It has been reported by Rebai and 
Djebli (2008) that increase in Al levels in the 
hippocampus and cortex causes damages, 
such as neurofibrillary degeneration, to these 
regions. Many studies have attributed NP-in-
duced toxicities to oxidative stress and in-
flammatory reactions (Adamcakova-Dodd et 
al., 2014; Ma et al., 2010). 
In conclusion, our findings suggest that 
short-term systemic exposure to Al2O3-NPs 
induces oxidative stress in the hippocampus. 
We also found that the latter possibly results 
from Al accumulation in the hippocampus 
and leads to changes in metabolic activity, 
thereby affecting learning and memory in 
rats. 
 
Funding sources 
This research did not receive any specific 
grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
Conflicts of interest 
None. 
 
REFERENCES 
Abdel-Aal RA, Assi AAA, Kostandy BB. Rivastig-
mine reverses aluminum-induced behavioral changes 
in rats. Eur J Pharmacol 2011;659:169-76.  
Adamcakova-Dodd A, Stebounova LV, Kim JS, 
Vorrink SU, Ault AP, O’Shaughnessy PT, et al. 
Toxicity assessment of zinc oxide nanoparticles using 
sub-acute and sub-chronic murine inhalation models. 
Part Fibre Toxicol. 2014;11:15.  
Aebi H. Oxygen radicals in biological systems. 
Methods Enzymol 1984; 05:121-6.  
Åkerman ME, Chan WCW, Laakkonen P, Bhatia SN, 
Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl 
Acad Sci U S A. 2002;99:12617-21. 
Amara S, Ben-Slama I, Mrad I, Rihane N, Jeljeli M, 
El-Mir L, et al. Acute exposure to zinc oxide nano-
particles does not affect the cognitive capacity and 
neurotransmitters levels in adult rats. Nanotoxicology. 
2014;8(Suppl 1):208-15.  
Balasubramanyam A, Sailaja N, Mahboob M, Rahman 
MF, Misra S, Hussain SM, et al. Evaluation of geno-
toxic effects of oral exposure to Aluminum oxide na-
nomaterials in rat bone marrow. Mutat Res. 2009;676: 
41-7. 
Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, 
Waggoner AS. Noninvasive imaging of quantum dots 
in mice. Bioconjug Chem. 2004;15:79-86. 
Banks WA, Niehoff ML, Drago D, Zatta P. Aluminum 
complexing enhances amyloid β protein penetration of 
blood-brain barrier. Brain Res. 2006;1116:215-21.  
Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan 
H, Donaldson K, et al. The potential risks of nano-
materials: a review carried out for ECETOC. Part Fibre 
Toxicol. 2006;14:3-11.  
Canales JJ, Corbalán R, Montoliu C, Llansola M, 
Monfort P, Erceg S, et al. Aluminium impairs the 
glutamate-nitric oxide-cGMP pathway in cultured 
neurons and in rat brain in vivo: Molecular 
mechanisms and implications for neuropathology. J 
Inorg Biochem. 2001;87:63-9.  
Chen L, Yokel RA, Hennig B, Toborek M. Manu-
factured aluminum oxide nanoparticles decrease 
expression of tight junction proteins in brain 
vasculature. J Neuroimmune Pharmacol. 2008;3:286-
95.  
Cupaioli FA, Zucca FA, Boraschi D, Zecca L. 
Engineered nanoparticles. How brain friendly is this 
new guest? Prog Neurobiol. 2014;119-120:20-38.  
EXCLI Journal 2018;17:200-210 – ISSN 1611-2156 
Received: December 20, 2017, accepted: February 10, 2018, published: February 14, 2018 
 
 
209 
De Jong WH, Hagens WI, Krystek P, Burger MC. 
Particle size-dependent organ distribution of gold 
nanoparticles after intravenous administration. Bio-
materials. 2008; 29:1912-9.  
Deguil J, Chavant F, Lafay-Chebassier C, Pérault-
Pochat MC, Fauconneau B, Pain S. Neuroprotective 
effect of PACAP on translational control alteration and 
cognitive decline in MPTP parkinsonian mice. 
Neurotox Res. 2010;17:142-55.  
Ellman GL. Tissue sulfhydryl groups. Arch Biochem 
Biophys. 1959;82:70-7.  
Ellman GL, Courtney KD, Andres VJR, Featherstone 
RM. A new and rapid colorimetric of acetylcholin-
esterase determination. Biochim Pharmacol. 1961;7: 
88-95. 
Flohé L, Günzler WA. Assays of glutathione 
peroxidase. Meth Enzymol. 1984;105:114-20. 
Flora SJS, Mittal M, Mehta A. Heavy metal induced 
oxidative stress & its possible reversal by chelation 
therapy. Indian J Med Res. 2008;128:501-23. 
Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer 
J, Gauvreau D. Aluminum forms in drinking water and 
risk of Alzheimer’s disease. Environ Res. 2000;84: 
234-46.  
Ghanta SR, Muralidharan K. Chemical synthesis of 
aluminum nanoparticles. J Nanoparticle Res. 2013;15: 
1715.  
Hartree EF. Determination of protein: a modification 
of the Lowry method that gives a linear photometric 
response. Anal Biochem. 1972;48:422-7.  
Kaizer RR, Corrêa MC, Gris LRS, Da Rosa CS, Bohrer 
D, Morsch VM et al. Effect of long-term exposure to 
aluminum on the acetylcholinesterase activity in the 
central nervous system and erythrocytes. Neurochem 
Res. 2008;33:2294-301.  
Karmakar A, Zhang Q, Zhang Y. Neurotoxicity of 
nanoscale materials. J Food Drug Anal. 2014; 22:147-
60.  
Kumar A, Dogra S, Prakash A. Protective effect of 
curcumin (Curcuma longa), against aluminium 
toxicity: Possible behavioral and biochemical 
alterations in rats. Behav Brain Res. 2009;205:384-90.  
Kumar A, Prakash A, Dogra S. Neuroprotective effect 
of carvedilol against aluminium induced toxicity: 
possible behavioral and biochemical alterations in rats. 
Pharmacol Rep. 2011;63:915-23.  
Leardi A, Caraglia M, Selleri C, Pepe SF, Pizzi C, No-
taro R, et al. Desferioxamine increases iron depletion 
and apoptosis induced by ara-C of human myeloid leu-
kaemic cells. Brit J Haematol. 1998;102:746-52. 
Li XB, Zheng H, Zhang ZR, Li M, Huang ZY, 
Schluesener HJ, et al. Glia activation induced by 
peripheral administration of aluminum oxide nano-
particles in rat brains. Nanomedicine. 2009;5:473-9.  
Lockman PR, Koziara JM, Mumper RJ, Allen DD. 
Nanoparticle surface charges alter blood-brain barrier 
integrity and permeability. J Drug Target. 2004;12: 
635-41.  
Ma L, Liu J, Li N, Wang J, Duan Y, Yan J, et al. 
Oxidative stress in the brain of mice caused by 
translocated nanoparticulate TiO2 delivered to the 
abdominal cavity. Biomaterials. 2010;31:99-105.  
Misra HP, Fridovich I. The role of superoxide anion in 
the autoxidation of epinephrine and a simple assay for 
superoxide dismutase. J Biol Chem. 1972; 247:3170-5.  
Miziolek AW. Nanoenergetics: an emerging technol-
ogy area of national importance. Amptiac Q. 2002;6: 
43-8. 
Monteiro-Riviere NA, Oldenburg SJ, Inman AO. Inter-
actions of aluminum nanoparticles with human epider-
mal keratinocytes. J Appl Toxicol. 2010;30:275-85. 
Morris R. Developments of a water-maze procedure 
for studying spatial learning in the rat. J. Neurosci 
Methods. 1984;11:47-60. 
Morsy GM, Abou El-Ala KS, Ali AA. Studies on fate 
and toxicity of nanoalumina in male albino rats: 
lethality, bioaccumulation and genotoxicity. Toxicol 
Ind Health. 2013;32:200-14.  
Oberdörster G, Oberdörster E, Oberdörster J. Nano-
toxicology: An emerging discipline evolving from 
studies of ultrafine particles. Environ Health Perspect. 
2005;113:823-39.  
Ohkawa H, Ohishi N, Yagi K. Assay for lipid per-
oxides in animal tissues by thiobarbituric acid reaction. 
Anal Biochem. 1979;95:351-8.  
Pakrashi S, Dalai S, Humayun A, Chakravarty S, 
Chandrasekaran N, Mukherjee A. Ceriodaphnia dubia 
as a potential bio-indicator for assessing acute alumi-
num oxide nanoparticle toxicity in fresh water environ-
ment. Plos One. 2013;8:1-13. 
Piercey DG, Klapoetke TM. Nanoscale aluminum - 
metal oxide (thermite) reactions for application in 
energetic materials. Cent Eur J Energ Mater. 2010; 
7:115-29. 
EXCLI Journal 2018;17:200-210 – ISSN 1611-2156 
Received: December 20, 2017, accepted: February 10, 2018, published: February 14, 2018 
 
 
210 
Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium 
toxicity in the rat brain: histochemical and immuno-
cytochemical evidence. Brain Res Bull. 2001;55:257-
67. 
Prabhakar P, Reddy U, Singh S, Balasubramanyam A, 
Rahman M, Indu Kumari S, et al. Oxidative stress 
induced by aluminum oxide nanomaterials after acute 
oral treatment in Wistar rats. J Appl Toxicol. 2012;32: 
436-45.  
Rabe A, Lee MH, Shek J, Wisniewski HM. Learning 
note deficit in immature rabbits with aluminum-
induced neurofibrillary changes. Exp Neurol. 1982; 
72:441-6. 
Rebai O, Djebli NE. Chronic exposure to aluminum 
chloride in mice: exploratory behaviors and spatial 
learning. Adv Biol Res. 2008;2:26-33. 
Sajid M, Ilyas M, Basheer C, Tariq M, Daud M, Baig 
N, et al. Impact of nanoparticles on human and 
environment: review of toxicity factors, exposures, 
control strategies, and future prospects. Environ Sci 
Pollut Res. 2015;22:4122-43.  
Sethi P, Jyoti A, Singh R, Hussain E, Sharma D. 
Aluminium-induced electrophysiological, biochemical 
and cognitive modifications in the hippocampus of 
aging rats. Neurotoxicology. 2008;29:1069-79.  
Shah SA, Yoon GH, Ahmad A, Ullah F, Amin FU, 
Kim MO. Nanoscale-alumina induces oxidative stress 
and accelerates amyloid beta (Aβ) production in ICR 
female mice. Nanoscale. 2015;7:15225-37.  
Sharma HS, Sharma A. Nanoparticles aggravate heat 
stress induced cognitive deficits, blood-brain barrier 
disruption, edema formation and brain pathology. Prog 
Brain Re. 2007;162:245-73.  
Sharma V, Singh P, Pandey AK, Dhawan A. Induction 
of oxidative stress, DNA damage and apoptosis in 
mouse liver after sub-acute oral exposure to zinc oxide 
nanoparticles. Mutat Res. 2012;745:84-91.  
Shrivastava R, Raza S, Yadav A, Kushwaha P, Flora 
SJS. Effects of sub-acute exposure to TiO2, ZnO and 
Al2O3 nanoparticles on oxidative stress and histol-
ogical changes in mouse liver and brain. Drug Chem 
Toxicol. 2014;37:336-47.  
Tripathi S, Mahdi AA, Nawab A, Chander R, Hasan 
M, Siddiqui MS, et al. Influence of age on aluminum 
induced lipid peroxidation and neurolipofuscin in 
frontal cortex of rat brain: A behavioral, biochemical 
and ultrastructural study. Brain Res. 2009;1253:107-
16.  
Tyner KM, Schiffman SR, Giannelis EP. Nanobio-
hybrids as delivery vehicles for camptothecin. J 
Control Release. 2004;95:501-14.  
Wagner AJ, Bleckmann CA, Murdock RC, Schrand 
AM, Schlager JJ, Hussain SM. Cellular interaction of 
different forms of aluminum nanoparticles in rat 
alveolar macrophages. J Phys Chem B. 2007;111: 
7353-9. 
Wang L, Hu J, Zhao Y. Effects of aluminium on β-
amyloid (1–42) and secretases (APP-cleaving 
enzymes) in rat brain. Neurochem Res. 2014;39:1338-
45.  
Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative 
study of cytotoxicity, oxidative stress and genotoxicity 
induced by four typical nanomaterials: The role of 
particle size, shape and composition. J Appl Toxicol. 
2009;29:69-78.  
Yokel RA. The toxicology of aluminium in the brain: 
a review. Neurotoxicology. 2000;21:813-28. 
Zatta P, Zambenedetti P, Kilyen M, Kiss T. In vivo and 
in vitro effects of aluminum on the activity of mouse 
brain acetylcholinesterase. Brain Res Bull. 2002;59: 
41-4.
 
